Russia may ban popular flu medication
Published
Vladimir Chulanov, the Russian Ministry of Health's chief freelance specialist in infectious diseases, has put forward an important initiative. The expert has proposed officially withdrawing the drug "Rimantadine," which has been used to treat the flu for decades, from medical circulation.
The primary reason for this decision is the drug's low efficacy. According to Chulanov, modern strains of the influenza virus have adapted to the drug's components. Currently, the virus's resistance to "Rimantadine" has exceeded 90%, making it virtually useless for patients.
The medical community notes that using ineffective drugs can be dangerous. When a patient takes a medication that does not fight the infection, the disease can progress, and the risk of developing complications increases significantly.
At the moment, no official order to remove the drug from pharmacies has been issued. It is expected that Ministry of Health experts will review this proposal and make a decision regarding the future of the medication in the near future.
Specialists remind the public that upon the first signs of a cold or flu, it is necessary to consult a doctor. Self-medicating with outdated drugs can be not only ineffective but also harmful to one's health.
Sources: ГИПОРТ
More Russia news
- Russia Is Developing Its First Private Ultralight Launch Vehicle, Voronezh
- Positive Technologies increased shipments by 54% in the first nine months of 2026
- The Desire to Leave and Actual Emigration: Why the Gap Is So Large
- Putin Praises Belarus's Assistance in Humanitarian Exchanges
- Putin: Cooperation between Belarus and Russia Is Developing at a Good Pace
- Ukraine and G7 countries discuss protection against air strikes and sanctions against Russia
- The number of patients with respiratory diseases in Russia has risen by 30%
- One in Four Europeans Suffers from Mental Disorders